Kodiak Sciences 1 article

Kodiak Sciences is an antibody and protein-therapeutics company whose biologic strategy centers on antibody biopolymer conjugate platform, with ABC ophthalmic drug technology defining a key target, format or immune mechanism. A further layer of its biologics work includes anti-VEGF retinal therapeutics and neovascular age-related macular degeneration, with diabetic macular edema therapeutics providing the disease, target or immune-mechanism context. For entity matching, binding format and drug molecule are separate from the organization; Kodiak Sciences is also associated with ocular biologic durability engineering.